INVA Q2 2018 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+14.6% YoY

Gross Profit

$67M100.0% margin

Operating Income

$63M93.4% margin

Net Income

$55M81.4% margin

EPS (Diluted)

$0.49

QoQ Revenue Growth

+28.1%

Cash Flow

Operating Cash Flow

$52M

Free Cash Flow

$52M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$339M

Total Liabilities

$494M

Stockholders' Equity

-$157M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$59M	+14.6%
Gross Profit	$67M	$58M	+15.2%
Operating Income	$63M	$48M	+31.0%
Net Income	$55M	$35M	+55.4%